About the Division of Carcinogenesis
We are currently focusing on refractory gastrointestinal cancers such as stomach, pancreas, and hepatocellular carcinoma, as well as lung cancer. Main research interest is the interaction between cancer cells and the tumor microenvironment, such as immune cells and fibroblasts that exist in the surrounding environment. Our goal is to conduct research that will lead to the development of theoretically based therapies based on an understanding of the complexity of not only cancer cells but also the surrounding cells, and to achieve a milestone toward the eradication of cancer. To date, I have conducted cancer research with nearly 20 graduate students, many of whom have gone on to study at overseas research facilities, and I also provide support for students to study abroad after obtaining their PhD degrees. I’m looking for members who share our interests and goals and will work together with us to conduct research that can be fed back to cancer patients in the future.
2023.8.1
The Cancer Institute, Division of Carcinogenesis, Chief
Takatsugu Ishimoto, M.D., Ph.D.
News
- 2025.01.02News
Review article by Masaya Yamazaki was published in Cancer Science. Details - 2024.11.25News
Japanese Review article by Akiho Nishimura was published in 臨床免疫・アレルギー科(KAGAKU-HYORONSHA). Details - 2024.10.22News
Review article by Takashi Semba was published in British Journal of Cancer. Details - 2024.10.01News
Kota Muraki (Keio University) joined our lab as a trainee! - 2024.10.09Award Information
Takashi Semba received the Cancer Society of Japan Encouragement Award at the 83rd Annual Meeting of the Japanese Cancer Association in 2024. Details - Click here for past announcements